课题基金 / 基金详情

Overcome HIV-1 Resistance to CRISPR/Cas9 Attack

Overcome HIV-1 Resistance to CRISPR/Cas9 Attack
克服 HIV-1 对 CRISPR/Cas9 攻击的抵抗力
批准号：
350800
负责人：
Liang Chen
金额：
$18.21万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-06-01 至 2017-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=350800&lang=en
关键词：
Crispr/Cas9 Cure Hiv/Aids Viral Resistance

项目摘要

项目成果

Liang Chen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
HIV infection continues to be a pandemic disease, with 36 million people carrying this deadly virus and 2 million new infections every year. The antiretroviral therapy is able to suppress HIV levels in patients below the detection limit of the sensitive R
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigate the immune modulation function of SARS-CoV-2 accessory protein ORF8
COVID-19 Variant Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
Understanding the NMD regulatory path from genetic variation to phenotypes
海外基金